In the past three years, the share price of Genocea Biosciences, Inc. (NASDAQ:GNCA) has struggled to grow and now shareholders are sitting on a loss. However, what is unusual is that EPS growth has ...

Genocea Biosciences, Inc. GNCA announced that it has initiated a phase I/IIa TiTAN study on its investigational neoantigen-targeted T-Cell therapy, GEN-011, by dosing the first patient in the study.

A vaccine developer focused on fighting infectious diseases like HSV-2, Pneumococcus and malaria has just gotten a $30 million vote of confidence from investors. Genocea Biosciences says its ATLAS ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, a vaccine discovery and development company, today announced the license to 14 antigens to Chlamydia trachomatis discovered in the lab of Dr.

Genocea Biosciences is winding down operations following a vote by the company’s board of directors Tuesday morning. Genocea is laying off all remaining employees except those deemed necessary to ...

Just weeks ago, Genocea Biosciences was touting phase 1/2 data that seemed to provide proof of concept for the biotech’s T cell therapy in patients with solid tumors at the American Association for ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

* Genocea Biosciences Inc - expects to file an investigational new drug (ind) application by early 2018. For ‍Gen-009 * Genocea Biosciences Inc - ‍Genocea is ceasing Gen-003 spending and activities ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced the closing of the ...

Good morning, and welcome to the Genocea Fourth Quarter 2021 Conference Call. [Operator Instructions]. Please be advised that this call is being recorded at the company's request. At this time, I'd ...

Good day. Thank you for standing by and welcome to the Second Quarter 2021 Corporate Update Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will ...